Literature DB >> 16083969

Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis.

Lis R V Antonelli1, Walderez O Dutra, Roque P Almeida, Olivia Bacellar, Edgar M Carvalho, Kenneth J Gollob.   

Abstract

Leishmaniasis is an important parasitic disease affecting millions worldwide. In attempts to understand the clinical relevance of immunological measurements as determined using flow cytometry, several immunological phenotypes were determined for a group of well defined human leishmaniasis patients and correlated with clinical measurements of the disease (Montenegro skin test (MST) and lesion area). The analysis demonstrated a positive correlation between the MST size and the frequency of ex vivo recent activated CD4(+) T cells. In contrast, higher frequencies of recent activated CD8(+) T cells were correlated with a smaller MST size. Moreover, a positive correlation was observed between the lesion total area and the frequency of activated CD69(+) (ex vivo) and CD40L(+) (cultured with Leishmania soluble antigen (SLA)) T lymphocytes. Finally, larger lesions were also correlated with a higher frequency of SLA specific inflammatory cytokine (IFN-gamma or TNF-alpha) producing lymphocytes. These studies demonstrate that immunological markers are correlated with clinical indicators of human leishmaniasis and serve to better understand the evolution of this important parasitic disease.

Entities:  

Mesh:

Year:  2005        PMID: 16083969     DOI: 10.1016/j.imlet.2005.06.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  91 in total

1.  Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Authors:  C de Oliveira Mendes-Aguiar; R Vieira-Gonçalves; L H Guimarães; M P de Oliveira-Neto; E M Carvalho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

2.  Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline.

Authors:  Graça Brito; Mayra Dourado; Ludmila Polari; Daniela Celestino; Lucas P Carvalho; Adriano Queiroz; Edgar M Carvalho; Paulo R L Machado; Sara Passos
Journal:  Am J Trop Med Hyg       Date:  2014-02-24       Impact factor: 2.345

3.  CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

Authors:  T S L Keesen; L R V Antonelli; D R Faria; L H Guimarães; O Bacellar; E M Carvalho; W O Dutra; K J Gollob
Journal:  Clin Exp Immunol       Date:  2011-07-04       Impact factor: 4.330

4.  Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis.

Authors:  Graça Brito; Mayra Dourado; Luiz Henrique Guimarães; Everson Meireles; Albert Schriefer; Edgar Marcelino de Carvalho; Paulo Roberto Lima Machado
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

5.  Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis.

Authors:  Fabiano Oliveira; Andre Bafica; Andrea B Rosato; Cecilia B F Favali; Jackson M Costa; Virginia Cafe; Manoel Barral-Netto; Aldina Barral
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

6.  Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.

Authors:  Ciara Gimblet; Jacquelyn S Meisel; Michael A Loesche; Stephen D Cole; Joseph Horwinski; Fernanda O Novais; Ana M Misic; Charles W Bradley; Daniel P Beiting; Shelley C Rankin; Lucas P Carvalho; Edgar M Carvalho; Phillip Scott; Elizabeth A Grice
Journal:  Cell Host Microbe       Date:  2017-06-29       Impact factor: 21.023

7.  Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Authors:  Rúbia S Costa; Lucas P Carvalho; Taís M Campos; Andréa S Magalhães; Sara T Passos; Albert Schriefer; Juliana A Silva; Ednaldo Lago; Camilla S Paixão; Paulo Machado; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

Review 8.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

9.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.